therapeutic 1,269 words KG: ent-gene-efa85237 2026-03-23
kind:therapeuticsection:therapeuticsstate:published
Contents

NfL-Guided Neuroprotection Threshold

🔬 Protein Info
Gene Symbolent-gene-efa85237
Trial/StudyDisease
TANGO (Tofersen)ALS
NUVAXOVIDALS
MS-SATELITEMS
DIAN-TUAlzheimer's
Endpoint TypeStatus
PrognosticModerate
PharmacodynamicStrong
SurrogateWeak
Age GroupNormal Plasma NfL (pg/mL)
20-40< 8
40-60< 12
60-80< 20
> 80< 25
DiseaseNfL Threshold
KG Connections2 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (6)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar
Score: 0.48
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57
Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.48

Related Analyses (4)

Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (13)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40

Knowledge Graph (2 edges)

ent-gene-efa85237 data_in benchmark_ot_ad_answer_key:NFL
benchmark_ot_ad_answer_key:NFL data_in ent-gene-efa85237